Shares of Altimmune (NASDAQ:ALT) rallied 30% in afternoon trading after the company issued several business updates along ...
UBS Global Wealth Management has cut its forecast for Chinese equities due to rising concerns over potential US tariffs and a ...
The review concerns Russian customers at Credit Suisse that UBS is now in charge of after rescuing the lender, two of the ...
In a report released today, Jason Napier from UBS maintained a Buy rating on Intesa Sanpaolo SpA (0HBC – Research Report). The ...
We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
UBS analyst Geoff Haire maintained a Hold rating on BASF SE ... corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders ...
Stay informed on UBS Group stock performance and updates with expert analysis and insights from our financial writer.
In this piece, we will take a look at where Home Depot, Inc. (NYSE:HD) ranks on the list of the top UBS AI and growth era.
PB Fintech's new initiatives will help it achieve EBITDA break-even by FY27, and a steady renewals pool should support ...
UBS Group AG expects rich Australians to seek more investment outside the country as assets grow and they want to diversify ...
UBS launched its coverage of Sagimet Biosciences (NASDAQ:SGMT) with a buy recommendation and a $12 price target, calling the company an underappreciated player in the market for liver disorder, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback